Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Fluorouracil × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 21 Stomach Neoplasms 15 Esophageal Neoplasms 9 Adenocarcinoma Of Esophagus 9 Carcinoma, Non-Small-Cell Lung 8 Squamous Cell Carcinoma of Head and Neck 7 Rectal Neoplasms 7 Pancreatic Neoplasms 7 Neoplasm Metastasis 6 Colonic Neoplasms 6 Neoplasms 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Ovarian Neoplasms 4 Urinary Bladder Neoplasms 3 Lung Neoplasms 3 Cholangiocarcinoma 3 Adenocarcinoma 3 Oropharyngeal Neoplasms 2 Head and Neck Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Endometrial Neoplasms 2 Colorectal Adenocarcinoma 2 Carcinoma, Pancreatic Ductal 2 Carcinoma 2 Anus Neoplasms 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Tongue Neoplasms 1 Small Cell Lung Carcinoma 1 Sinonasal undifferentiated carcinoma 1

Interventions

pembrolizumab 15 enfortumab vedotin 10 Specimen Handling 9 Magnetic Resonance Spectroscopy 9 Nivolumab 7 Carboplatin 5 avelumab 4 Ipilimumab 4 Gemcitabine 4 Docetaxel 4 Cisplatin 4 sacituzumab govitecan 3 Paclitaxel 3 cabozantinib 2 Taxes 2 CTLA-4 Antigen 2 Biopsy 2 zimberelimab 1 zanidatamab 1 tazemetostat 1 soluble LAG-3 protein, human 1 sargramostim 1 sapanisertib 1 relatlimab 1 regorafenib 1 lenvatinib 1 eribulin 1 erdafitinib 1 durvalumab 1 dodecyl maltoside 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡